跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EDC-8
首页
药物
EDC-8
EDC-8
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Magnetic nano-drug with double targeting VEGF-VEGFR, and preparation method and application thereof
申请人: THE THIRD CLINICAL MEDICAL COLLEGE NANJING UNIV OF CHINESE MEDICINE
优先权: 2023
CN
US
3 件公开
Green synthesis method of 2-trifluoromethylindole
申请人: SINOPHARM CHEMICAL REAGENT CO LTD
优先权: 2021
CN
Preparation method of streptavidin conjugate
申请人: DING WEILI
优先权: 2013
CN
Macrophage-oncolytic virus coupling system as well as preparation method and application thereof in preparation of antitumor drugs
申请人: GUOKE WENZHOU RES INSTITUTE WENZHOU INSTITUTE OF BIOMATERIALS AND ENGINEERING
优先权: 2024
CN
Method for fixing metal organic framework material ZIF-8 and loading anti-inflammatory drug on surface of chitosan substrate material under assistance of hydroxycaffeic acid
申请人: UNIV XI AN JIAOTONG
优先权: 2025
CN
一种微交联重组胶原蛋白关节软骨修复凝胶及其制备方法
申请人: 河北纳科生物科技有限公司
优先权: 2024
CN
Method for continuously preparing N-hydroxysuccinimide fatty acid ester
申请人: SHANGHAI WOKAI BIOTECHNOLOGY CO LTD
优先权: 2025
CN
Biocompatible and bioabsorbable derivatized chitosan compositions
申请人: HEMCON MEDICAL TECH INC
优先权: 2014
CN
US
7 件公开
药物
反馈